↓ Skip to main content

Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients

Overview of attention for article published in Annals of Hematology, March 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
26 Mendeley
Title
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients
Published in
Annals of Hematology, March 2019
DOI 10.1007/s00277-019-03662-6
Pubmed ID
Authors

Francesco Gaudio, Patrizio Mazza, Anna Mele, Giulia Palazzo, Angelo Michele Carella, Mario Delia, Giovanni Pisapia, Domenico Pastore, Nicola Cascavilla, Vincenzo Pavone, Giorgina Specchia

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Other 7 27%
Researcher 3 12%
Student > Bachelor 2 8%
Student > Postgraduate 2 8%
Unknown 12 46%
Readers by discipline Count As %
Medicine and Dentistry 7 27%
Biochemistry, Genetics and Molecular Biology 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Agricultural and Biological Sciences 1 4%
Nursing and Health Professions 1 4%
Other 2 8%
Unknown 12 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2019.
All research outputs
#15,564,321
of 23,133,982 outputs
Outputs from Annals of Hematology
#1,176
of 2,208 outputs
Outputs of similar age
#220,282
of 351,896 outputs
Outputs of similar age from Annals of Hematology
#23
of 46 outputs
Altmetric has tracked 23,133,982 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,208 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,896 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.